Tomi Sawyer
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$2.2MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 15, 2022 | NIH | STTR Phase II Development of Novel Melanocortin-4 Receptor Peptide Agonists for the Treatment ofMC4R Haploinsufficiency | $1.7M | COURAGE THERAPEUTICS INC with UNIVERSITY OF MICHIGAN |
| May 1, 2021 | NIH | STTR Phase I Development of Melanocortin-3 Receptor Peptide Agonists for the Treatment of Anorexia Nervosa | $251K | COURAGE THERAPEUTICS INC with UNIVERSITY OF MICHIGAN |
| Sep 11, 2020 | NIH | STTR Phase I Development of Melanocortin-3 Receptor Peptide Antagonists for the Treatment of Obesity and Maintenance of Weight Loss | $245K | COURAGE THERAPEUTICS INC with UNIVERSITY OF MICHIGAN |
Peer ranks
Federal funding#920
Awards as PI#822
Patents#273
Companies
- COURAGE THERAPEUTICS INCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.